Caretta N, Palego P, Ferlin A, Garolla A, Bettella A, Selice R, Foresta C
Department of Histology, Microbiology and Medical Biotechnologies, Centre for Male Gamete Cryopreservation, University of Padova, Via Giustiniani 2, 35128-Padova, Italy.
Eur Urol. 2005 Aug;48(2):326-31; discussion 331-2. doi: 10.1016/j.eururo.2005.01.013. Epub 2005 Feb 5.
To evaluate the possible improvement of sexual activity following a non on-demand administration of a long half-life selective inhibitor of phosphodiesterase type 5 (PDE-5) in elderly patients without major cardiovascular risk factors.
Sixty subjects with erectile dysfunction (ED) aged 60-70 years and 30 control patients aged 18-40 years, affected by psychogenic ED, were studied. All underwent routine and hormonal blood tests, Nocturnal Penile Tumescence Rigidity Monitoring test (NPTRM), ultrasonographyc evaluation of common carotid artery intima-media thickness (IMT) and penile colour Doppler ultrasonography (P-CDU). All patients underwent therapy with tadalafil 20 mg in alternative days, non on-demand, at 5.00 p.m., for three consecutive months. IIEF-5, NPTRM test and P-CDU were re-evaluated one month after the end of the therapy.
Among elderly subjects 20 (33%) had normal carotid IMT (< 0.9 mm), 15 (25%) minimal increase of carotid thickness (IMT = 0.9-1.2 mm) and 25 (42%) one or more carotid plaques (IMT > 1.3 mm). NPTRM and P-CDU parameters were inversely related to different degrees of carotid wall alteration and showed a significant improvement respect to pre-treatment only in patients without atherosclerotic plaques. Also IIEF-5 showed significant improvements only in patients without atherosclerotic plaques.
In elderly subjects with slight or no signs of vascular disease at the carotid level, chronic and non on-demand treatment with tadalafil can induce spontaneous resumption of erections, probably through the improvement of endothelial function, but direct evidences to confirm this hypothesis are required.
评估在无重大心血管危险因素的老年患者中,非按需服用长效5型磷酸二酯酶(PDE-5)选择性抑制剂后性功能的可能改善情况。
研究了60名年龄在60至70岁的勃起功能障碍(ED)患者以及30名年龄在18至40岁、患有心因性ED的对照患者。所有患者均接受了常规血液检查和激素检查、夜间阴茎肿胀硬度监测测试(NPTRM)、颈动脉内膜中层厚度(IMT)的超声评估以及阴茎彩色多普勒超声检查(P-CDU)。所有患者在下午5点每隔一天非按需服用20毫克他达拉非,持续三个月。在治疗结束后一个月重新评估国际勃起功能指数-5(IIEF-5)、NPTRM测试和P-CDU。
在老年受试者中,20人(33%)颈动脉IMT正常(<0.9毫米),15人(25%)颈动脉厚度略有增加(IMT = 0.9至1.2毫米),25人(42%)有一个或多个颈动脉斑块(IMT>1.3毫米)。NPTRM和P-CDU参数与颈动脉壁不同程度的改变呈负相关,并且仅在没有动脉粥样硬化斑块的患者中相对于治疗前有显著改善。IIEF-5也仅在没有动脉粥样硬化斑块的患者中显示出显著改善。
在颈动脉水平有轻微血管疾病迹象或无血管疾病迹象的老年受试者中,长期非按需服用他达拉非可能通过改善内皮功能诱导勃起功能自发恢复,但需要直接证据来证实这一假设。